| ID | Name | CAS | Data |
MW (g/mol) |
| 39-491-4 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M (carboxy-HO-alkyl-), 2TMS
|
|
2 | 449.74 |
| 39-525-6 |
dl-5-Hydroxylysine, N,N,O-tris(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 619.25 |
| 39-543-6 |
Erythro-Pentonic acid, 2-deoxy-3,4,5-tris-O-(trimethylsilyl)-, trimethylsilyl ester
|
74742-30-6 |
2 | 438.85 |
| 39-570-6 |
3,7,11,15-Tetramethyl-2-hexadecenal, O-TBDMS oxime, # 2
|
|
2 | 423.80 |
| 39-653-4 |
Glycine, N-(2-methyl-1-oxo-2-propenyl)-, trimethylsilyl ester
|
55836-40-3 |
2 | 215.32 |
| 39-843-3 |
Androst-4-en-4-chloro-3«alpha»-ol-17-one, TMS
|
|
2 | 467.23 |
| 39-857-8 |
4-(2-Acetylamino-1-(tert-butyldimethylsilyloxy)ethyl)phenol, tert-butyldimethylsilyl ether
|
|
2 | 423.74 |
| 39-901-8 |
5«alpha»-Androstane-3,17-dione, 2-enol, per-TMS
|
|
2 | 432.79 |
| 40-037-6 |
Urea, 1-[2-(6-hydroxy-9h-purin-9-yl)ethyl]-3-methyl-
|
|
2 | 236.24 |
| 40-048-4 |
Androst-5,9(11)-diene-3-«beta»,17-«beta»-diol, TMS
|
|
2 | 432.79 |
| 40-127-6 |
Pyrimidine, 2,4-bis[(trimethylsilyl)oxy]-5-[[(trimethylsilyl)oxy]methyl]-
|
31517-04-1 |
2 | 358.66 |
| 40-163-6 |
N-(2-Hydroxy-2-phenyl-ethyl)-4-methyl-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 435.74 |
| 40-222-0 |
2,4(1H,3H)-Pyrimidinedione, dihydro-1,3-bis(trimethylsilyl)-
|
74810-47-2 |
2 | 258.46 |
| 40-258-1 |
4-Pregnen-20-«beta»-ol-3,11-dione, MO-TMS
|
|
2 | 460.72 |
| 40-280-6 |
3A,11B,17A,21-Tetrahydroxy-5A-pregnan-20-one, enol, tetrakis-TMS
|
|
2 | 655.22 |
| 40-320-1 |
5,6-Dichloro-1,3-benzothiazol-1-trimethylsilyl-2-(trimethylsilyl)imine
|
|
2 | 363.45 |
| 40-333-7 |
Urea, 1-methyl-1-nitroso-3-[2-(purin-8-ylthio)ethyl]-
|
|
2 | 281.29 |
| 40-466-0 |
1-Oxo-2-(3-phenylrhodanin-5-ylidene)-3-pyridinium-4-naphthoxide
|
|
2 | 442.51 |
| 40-565-0 |
17-«beta»-Hydroxy-17-«alpha»-methyl-5-«beta»-androst-1-en-3-one, per-TMS
|
|
2 | 446.81 |
| 40-579-5 |
cis-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, butylboronate
|
|
2 | 280.18 |
| 40-583-0 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)propoxy-
|
|
2 | 422.44 |
| 40-687-5 |
5,5'-Dichloro-[2,2'-azo-1,3,4-thiadiazol]
|
98020-86-1 |
2 | 267.12 |
| 40-704-5 |
Indoaniline dye, [1-hydroxy-2-(2,4,6-trimethyl)naphthanilide with 4-amino-n,n-diethyl-3-methylaniline]
|
114909-96-5 |
2 | 479.61 |
| 40-916-0 |
5«alpha»-Androstan-6«beta»-ol-3,17-dione,tris-TMS
|
|
2 | 520.97 |
| 41-243-6 |
myo-Inositol 3,4,5,6-tetraacetate, bis(trimethylsilyl) ether
|
|
2 | 492.67 |
| 41-338-1 |
3«alpha»,16«beta»,17«alpha»-Trihydroxy-5«alpha»-androstane, tris-TMS
|
|
2 | 525.00 |
| 41-616-2 |
Urea, 1-(2-fluoroethyl)-1-nitroso-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-
|
116277-64-6 |
2 | 245.17 |
| 41-628-9 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-6.«alpha»,17«beta»-diol, bisTBDMS
|
|
2 | 532.99 |
| 41-738-7 |
Cyclopentanecarboxylic aicd, 1-[3-(2-chloroethyl)-3-nitrosoureido]-, ethyl ester
|
13909-05-2 |
2 | 291.73 |
| 41-743-1 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3-O)-TMTBSi, (17,20-O)-diTMSi
|
|
2 | 595.13 |
| 42-193-1 |
1-(2,4-Dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol , trimethylsilanyl ether
|
|
2 | 398.40 |
| 42-247-1 |
3«beta»,11«beta»-Dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
2 | 522.98 |
| 42-285-9 |
3-oxy-7«alpha»,12«alpha»-dihydroxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
|
2 | 677.19 |
| 42-365-0 |
Arabino-Hexonic acid, 2-deoxy-3,5,6-tris-O-(trimethylsilyl)-, «gamma»-lactone
|
74778-25-9 |
2 | 378.68 |
| 42-388-5 |
Urea, 1-(2-fluoroethyl)-1-nitroso-3-(tetrahydro-2h-thiopyran-4-yl)-, s,s-dioxide
|
32319-89-4 |
2 | 267.28 |
| 42-399-3 |
9-Dodecyn-1-ol, dimethyl(pyrid-2-ylmethoxy)silyl ether
|
|
2 | 347.57 |
| 42-425-3 |
6-Azido-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-D-erythro-hexofuranose
|
|
2 | 285.41 |
| 42-479-4 |
Pyrrolidine, 1-[(4-amino-1,2,5-thiadiazol-3-yl)carbonyl]-
|
116374-00-6 |
2 | 198.25 |
| 42-542-3 |
5-Chloro-1-trimethylsilyl-indole-2-carboxylic acid, trimethylsilyl ester
|
|
2 | 339.97 |
| 42-626-0 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,17-O)-TBDMSi, (20-O)-TMSi
|
|
2 | 637.21 |
| 42-648-6 |
Methyl 5-«beta»-cholan-3-«alpha»,12-«alpha»-diol-7-one-24-oate, oxime, TMS
|
|
2 | 652.14 |
| 42-683-7 |
Silane, dimethyl(dimethyl(non-5-yn-3-yloxy)silyloxy)ethoxy-
|
|
2 | 316.59 |
| 42-714-2 |
5«beta»-Androstan-3«alpha»,11«beta»-diol-17-one, TMS
|
|
2 | 522.98 |
| 42-725-0 |
5-«alpha»-Pregnan-3-«beta»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 42-741-2 |
Kojitriose: aD-Glcp(1->2)-aDGlcp(1->2)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.65 |
| 42-821-3 |
1, 1'-Thiobis(2-methyl-4-trimethylsiloxy-5-tert-butylbenzene)
|
|
2 | 502.90 |
| 42-855-6 |
(3R,4R)-4-azido-3-tert-butyldimethylsilyloxy-1-tert-butoxycarbonylazepane
|
|
2 | 370.56 |
| 42-874-5 |
Pentanedioic acid, 2-[(tert-butyldimethylsilyl)oxy]-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 490.90 |
| 42-919-5 |
Triazole-4-carboxamide, (1h)-1,2,3-, 5-[(n-methyl-n-phenyl)-1-triazeno]-
|
7229-14-3 |
2 | 245.24 |
| 43-015-7 |
3A,17A,21-Trihydroxy-5B-pregnan-11,20-dione, enol, tetrakis-TMS
|
|
2 | 653.20 |
| 43-066-1 |
4-Pregnen-3-«beta»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 551.04 |
| 43-075-1 |
Galactonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55528-74-0 |
2 | 466.86 |
| 43-089-6 |
Ethanol, 2-[(6(1h)-oxo-9h-purin-2-yl)thio]- (keto form)
|
|
2 | 212.23 |
| 43-200-1 |
[4-(([1-(2-Chloroethyl)-2-oxohydrazino]carbonyl)amino)phenyl]acetic acid
|
|
2 | 285.69 |
| 43-408-1 |
1H-1,2,3-triazole-4-carboxamide, 5-(1-pyrrolidinylazo)-
|
|
2 | 209.21 |
| 43-515-2 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,7-«alpha»,12-«alpha»-tetrahydroxy, methyl ester, TMS
|
|
2 | 727.32 |
| 43-610-6 |
5-«beta»-Pregnan-3-«beta»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 43-618-8 |
Ethanol, 2,2'-[(9-benzyl-9h-purin-6-yl)imino]di-
|
|
2 | 313.35 |
| 43-692-6 |
4-Imidazolecarboxylic acid, 5-(3-methyltriazen-1-yl)-, methyl ester
|
36137-94-7 |
2 | 183.17 |
| 43-814-0 |
4-Pregnen-11-«beta»,20-«alpha»-diol-3-one, MO-TMS
|
|
2 | 505.88 |
| 43-863-6 |
7.alpha.-hydroxy-3-oxo-4-cholestenoate, O-methyloxime, TMS (2)
|
|
2 | 604.04 |
| 43-907-7 |
2-Deoxy-D-ribose, tris(trimethylsilyl) ether, trimethylsilyloxime (isomer 1)
|
|
2 | 437.87 |
| 43-985-1 |
5-«beta»-Cholestane, 3-«alpha»,7-«alpha»,12-«alpha»,27-tetraol, TMS
|
|
2 | 725.39 |
| 44-035-4 |
5-«beta»-Pregnan-3-one-11-«beta»-ol, MO-TMS
|
|
2 | 419.72 |
| 44-062-4 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17«beta»-ol, monoTBDMS
|
|
2 | 402.73 |
| 44-069-7 |
3«alpha»,5«beta»,7«beta»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 697.30 |
| 44-104-7 |
5-Cholesten-3-.beta.,7-.alpha.,12-.alpha.,26-tetrol, TMS
|
|
2 | 723.39 |
| 44-173-1 |
3«alpha»,16«alpha»,17«beta»-Trihydroxy-5«beta»-androstane, tris-TMS
|
|
2 | 525.00 |
| 44-331-5 |
3-«beta»,7-«alpha»-Dihydroxy-4-cholenoic acid, methyl ester, TMS
|
|
2 | 548.94 |
| 44-369-4 |
2-Glucosyl-cellobiose: aD-Glcp(1->2)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 44-462-0 |
2-(N-n-di-n-hexylamino)-3-(n-pentyl)-6-(n-heptyl) pyrazine
|
|
2 | 431.75 |
| 44-535-9 |
3A,11B,17A,20A,21-Pentahydroxy-5B-pregnane, tetrakis-TMS
|
|
2 | 657.23 |
| 44-595-3 |
Silane, [[(3«beta»,5«alpha»)-androstan-3-yl]oxy]trimethyl-
|
18899-44-0 |
2 | 348.64 |
| 44-638-5 |
d-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, «delta»-lactone
|
32384-65-9 |
2 | 466.86 |
| 44-653-8 |
ent-6«alpha»,7«alpha»,16«beta»,17-Tetrahydroxy-16,17-dihydrokaurenoic acid, Me-TMS
|
|
2 | 597.06 |
| 44-797-9 |
Oxalacetic acid, enol-(tert-butyldimethylsilyl) ether, bis(tert-butyldimethylsilyl) ester
|
|
2 | 474.85 |
| 44-819-4 |
ent-16«beta»,17-H2(OH)2 7«alpha»-OH kaurenoic acid, MeTMSi
|
|
2 | 583.03 |
| 44-870-7 |
2,2,4,4-Tetramethyl-1,3-cyclobutane-1,3-diol, cis, bis-TMS
|
|
2 | 288.58 |
| 44-885-1 |
Silane, dimethyl(2,2,3,3,4,4,5,5-octafluoropentyloxy)isohexyloxy-
|
|
2 | 390.39 |
| 44-907-6 |
cis-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, bis-TMS
|
|
2 | 358.62 |
| 45-040-7 |
O,O'-Bis(tert-butyldimethylsilyl) 2-amino-9-(2-hydroxyethoxymethyl)-purin-6-ol ether
|
|
2 | 453.73 |
| 45-193-8 |
Anthracene, 1,2,3,4-tetrahydro-cis-1,2-diol, DTBS
|
|
2 | 354.56 |
| 45-211-7 |
«alpha»-D-Glucopyranoside, 1,3,4,6-tetrakis-O-(trimethylsilyl)-«beta»-D-fructofuranosyl 2,3,4,6-tetrakis-O-(trimethylsilyl)-
|
19159-25-2 |
2 | 919.75 |
| 45-318-9 |
4-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TPS
|
|
2 | 687.11 |
| 45-336-9 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 45-583-5 |
2,6-Dimethyl-5-[(diphenylmethyl)silyloxy]non-1-en-3-yne
|
|
2 | 362.58 |
| 45-693-3 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, methylboronate, TMS
|
|
2 | 432.52 |
| 45-713-0 |
3«alpha»,7«alpha»,12«alpha»,26-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 769.40 |
| 45-776-1 |
4-METHYLHYDRAZONOMETHYL-2,2,5,5-TETRAMETHYL-3-IMIDAZOLINE-1-OXILE
|
|
2 | 197.26 |
| 45-844-5 |
4-Pregnen-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 551.04 |
| 45-881-4 |
Androsta-1,4-dien-17«beta»-ol-3-one,bis-TMS
|
|
2 | 430.77 |
| 45-913-8 |
3-«alpha»-12-«alpha»-Dihydroxy-7-keto-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 564.94 |
| 45-948-0 |
5-«beta»-Pregnan-20-«alpha»-ol-3,11-dione, MO-TMS
|
|
2 | 462.74 |
| 46-001-9 |
Methyl ([1,1,3,3,5,5-hexamethyl-5-(pyridin-3-ylmethoxy)trisiloxanyl]oxy)acetate
|
|
2 | 403.66 |
| 46-116-2 |
4H-1-Benzopyran-4-one, 2-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3,5,7-tris[(trimethylsilyl)oxy]-
|
4067-66-7 |
2 | 663.14 |
| 46-174-8 |
5-Methyl-7-amino-s-triazolo(1,5-a)pyrimidine
|
33376-96-4 |
2 | 149.15 |
| 46-177-5 |
3-«alpha»,7-«beta»,22-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
2 | 639.14 |
| 46-324-1 |
3-«beta»,15-«alpha»-Dihydroxy-5-androsten-17-one, MO TMS
|
|
2 | 477.83 |
| 46-408-8 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, O-methyloxime (2)
|
|
2 | 650.12 |
| 46-584-3 |
9-Dodecyn-1-ol, dimethyl(pyrid-3-ylmethoxy)silyl ether
|
|
2 | 347.57 |
|
« Previous Results
Next Results »
|